Progyny (NASDAQ:PGNY) Announces Quarterly Earnings Results
Progyny (NASDAQ:PGNY) Announces Quarterly Earnings Results
Progyny (NASDAQ:PGNY – Get Rating) released its earnings results on Thursday. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04, Briefing.com reports. The firm had revenue of $195.00 million for the quarter, compared to analysts' expectations of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 18.11%. Progyny's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter last year, the company earned $0.19 EPS.
普羅吉尼(納斯達克代碼：PGNY-GET Rating)週四發佈了財報。據Briefing.com報道，該公司公佈本季度每股收益為0.09美元，比普遍預期的0.05美元高出0.04美元。該公司當季營收為1.95億美元，高於分析師預期的1.9051億美元。Progyny的淨利潤率為7.39%，股本回報率為18.11%。與去年同期相比，Progyny的季度收入增長了51.5%。去年同一季度，該公司每股收益為0.19美元。
Progyny Price Performance
孕期性價比
Shares of PGNY traded up $11.38 during mid-day trading on Friday, hitting $41.15. The company's stock had a trading volume of 3,469,925 shares, compared to its average volume of 684,594. The firm has a 50-day moving average price of $30.23 and a 200 day moving average price of $37.34. The stock has a market capitalization of $3.78 billion, a price-to-earnings ratio of 89.46, a PEG ratio of 15.71 and a beta of 1.85. Progyny has a fifty-two week low of $25.67 and a fifty-two week high of $68.32.
在週五午盤交易中，PGNY的股價上漲了11.38美元，達到41.15美元。該公司股票的總成交量為3469,925股，而其平均成交量為684,594股。該公司的50日移動均線價格為30.23美元，200日移動均線價格為37.34美元。該股市值為37.8億美元，市盈率為89.46倍，市盈率為15.71倍，貝塔係數為1.85。Progyny的52周低點為25.67美元，52周高位為68.32美元。
Insider Transactions at Progyny
Progyny的內幕交易
In other Progyny news, Chairman David J. Schlanger sold 1,452 shares of the firm's stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the completion of the transaction, the chairman now directly owns 82,548 shares in the company, valued at $2,576,323.08. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Progyny news, Director Norman Payson sold 6,618 shares of the firm's stock in a transaction dated Wednesday, May 25th. The shares were sold at an average price of $32.09, for a total value of $212,371.62. Following the completion of the transaction, the director now directly owns 477,592 shares in the company, valued at $15,325,927.28. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Chairman David J. Schlanger sold 1,452 shares of the firm's stock in a transaction dated Monday, June 27th. The stock was sold at an average price of $31.21, for a total transaction of $45,316.92. Following the completion of the transaction, the chairman now owns 82,548 shares of the company's stock, valued at $2,576,323.08. The disclosure for this sale can be found here. Insiders have sold 41,240 shares of company stock valued at $1,291,601 in the last quarter. Insiders own 14.00% of the company's stock.
在Progyny的其他消息中，董事長大衞·J·施蘭格在6月27日星期一的交易中出售了1,452股該公司股票。這些股票的平均價格為31.21美元，總價值為45316.92美元。交易完成後，董事長現在直接擁有該公司82,548股，價值2,576,323.08美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過這個鏈接訪問。在Progyny的其他消息中，董事諾曼·佩森在一筆日期為5月25日星期三的交易中出售了6618股該公司股票。這些股票的平均價格為32.09美元，總價值為212,371.62美元。交易完成後，董事現在直接擁有該公司477,592股，價值15,325,927.28美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，可以通過這個鏈接訪問。此外，董事長大衞·J·施蘭格在一筆日期為6月27日星期一的交易中出售了1,452股公司股票。該股以31.21美元的平均價格出售，總成交金額為45316.92美元。交易完成後，董事長現在擁有82,548股公司股票，價值2,576,323.08美元。此次拍賣的披露信息可在此處找到。上個季度，內部人士已經出售了41,240股公司股票，價值1,291,601美元。內部人士持有該公司14.00%的股份。
Institutional Inflows and Outflows
機構資金流入和流出
Progyny Company Profile
Progyny公司簡介
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- MarketBeat：回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升，是時候收購了嗎？
- 蘋果為何可能在年底創下歷史新高
- Beyond Meat不是沒有希望，而且它很便宜
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。